Odysseus, Avocados, and Election Litigation Timing

MICHAEL C. DORF

Cornell law professor Michael C. Dorf explains the legal concepts of ripeness and laches, which pertain to the timing of filing a lawsuit, and argues that in the context of election lawsuits, it is far better for courts to relax ripeness rules and risk unnecessary adjudications than to discard the doctrine of laches and risk widespread disenfranchisement and the undermining of confidence in fair elections.

Read More

Effler v. Purdue Pharma L.P.

Docket: E2018-01994-SC-R11-CV

Opinion Date: December 17, 2020

Judge: Lee

Areas of Law: Drugs & Biotech

The Supreme Court held that the seven District Attorneys General who sued several drug companies under the Tennessee Drug Dealer Liability Act lacked standing and that the two Baby Doe plaintiffs who sued under the Act and alleged facts showing that the drug companies knowingly participated in the illegal drug market by facilitating the marketing or distribution of opioids stated a claim against the drug companies under the Act. The District Attorneys and the Baby Doe plaintiffs brought this action alleging that the defendant drug companies knowingly participated in the illegal drug market by intentionally flooding East Tennessee communities with prescription opioid medications. The Baby Doe plaintiffs alleged that they were harmed by exposure to opioids in utero and the District Attorneys claimed that the opioid epidemic had damaged the communities in their districts. The trial court dismissed the case, ruling that the Act did not apply. The court of appeals reversed. The Supreme Court affirmed in part and reversed in part, holding (1) the District Attorneys lacked standing to bring an action under the Act as individual plaintiffs; and (2) the Baby Doe plaintiffs stated a claim against the drug companies based on allegations of intentional and purposeful participation in the illegal opioid market.